TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.260nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.280nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.320nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.350nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.520nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 0.860nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 5.20nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 5.30nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 8.10nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 284nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Ibitecs, Cea
Curated by ChEMBL
Ibitecs, Cea
Curated by ChEMBL
Affinity DataIC50: 2.03E+3nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 2.05E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using tolbutamide as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using tolbutamide as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using mephenytoin as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using tolbutamide as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using tolbutamide as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using mephenytoin as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using mephenytoin as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate after 5 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Lindsey F. Kimball Research Institute
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using mephenytoin as substrate after 60 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 2.76E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 3.30E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 3.35E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 3.85E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 5.04E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 5.71E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 5.80E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 5.85E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 5.86E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 6.14E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 6.45E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 6.58E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 6.83E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 7.36E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 7.37E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 7.48E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Bryn Mawr College
Curated by ChEMBL
Bryn Mawr College
Curated by ChEMBL
Affinity DataIC50: 7.55E+4nMAssay Description:Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrsMore data for this Ligand-Target Pair